Evidence map›Paper›PMID 30648856›Full record

ArticleACS synthetic biology2019

An Artificial Pathway for Isoprenoid Biosynthesis Decoupled from Native Hemiterpene Metabolism.

Sean Lund, Rachael Hall, Gavin J Williams

Abstract read
In one paragraph

Article in ACS synthetic biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 110 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Synthesis of depressin, cryptomeridiol and 4-Beilstein journal of organic chemistry · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Substrate-Multiplexed Assessment of Aromatic Prenyltransferase Activity.Chembiochem : a European journal of chemical biology · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Confirmation of the stereochemistry of spiroviolene.Beilstein journal of organic chemistry · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sean Lund
Rachael Hall
North Carolina State University · US

Funding

Synthetic Biology Approach to Regioselectively Modified PolyketidesR01GM104258 · NIGMS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI WILLIAMS, GAVIN J · 2013 to 2017
$1.4M
NIGMS NIH HHS R01 GM104258
6 · The paper itself

Abstract

Isoprenoids are constructed in nature using hemiterpene building blocks that are biosynthesized from lengthy enzymatic pathways with little opportunity to deploy precursor-directed biosynthesis. Here, an artificial alcohol-dependent hemiterpene biosynthetic pathway was designed and coupled to several isoprenoid biosynthetic systems, affording lycopene and a prenylated tryptophan in robust yields. This approach affords a potential route to diverse non-natural hemiterpenes and by extension isoprenoids modified with non-natural chemical functionality. Accordingly, the prototype chemo-enzymatic pathway is a critical first step toward the construction of engineered microbial strains for bioconversion of simple scalable building blocks into complex isoprenoid scaffolds.

Indexed as

Biosynthetic PathwaysDimethylallyltranstransferaseHemiterpenesLycopeneMetabolic EngineeringTerpenesDimethylallyltranstransferaseHemiterpenesLycopeneTerpeneshemiterpeneisoprenoidskinaselycopeneprenyltransferaseterpenoids

Identifiers

PMID30648856
PMCPMC6556385
OpenAlexW2910613147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.